ÂÜÀòÂÒÂ×

Benedict C. Albensi, PhD, BCMAS, CRQM has a diverse and extensive work experience. Benedict C. currently serves as the Chair and Professor at Nova Southeastern University- College of Pharmacy since September 2021. Prior to that, they were the Editor-in-Chief of Molecular Neurobiology (journal) at Springer Nature Publisher since February 2020. From January 2018, Dr. Albensi worked as a Senior Editor/Associate Editor for the Journal of Alzheimer's Disease at IOS Press, where they contributed to the understanding and treatment of Alzheimer's disease. Benedict C. also served as a Scientific Advisory Board Member at Intracell Research Group starting in October 2021.

Dr. Albensi has made significant contributions in the field of neuroscience through their role as the Associate Editor for Brain Injury (journal) at Taylor & Francis Group Pub., Official Journal of the International Brain Injury Assoc since 2014. Benedict C. oversees the peer review process for brain research studies and makes decisions on their acceptance or rejection. Additionally, Dr. Albensi is an Investigator Member of the Canadian Consortium on Neurodegeneration in Aging since July 2017.

Their extensive experience in grant review committees is evident from their involvement in over 30 grant review committees, including those of the National Institutes of Health, since January 2000. Furthermore, they have held the position of Adjunct Principal Investigator and Everett Endowment Fund Chair (Alzheimers) at St. Boniface Hospital since April 2011.

Dr. Albensi is actively engaged in various leadership roles in the academic and scientific communities. Benedict C. has been serving as the Chair of the Executive Committee - Nutrition, Metabolism, & Dementia PIA at Alzheimer's Association®® ISTAART PIA since October 2020. Additionally, they served as a Board Director for the MitoCanada Foundation from September 2015 to November 2021.

Overall, Dr. Albensi's work experience highlights their expertise and dedication to advancing the understanding and treatment of neurological diseases, particularly Alzheimer's disease and brain injury.

Benedict C. Albensi, PhD, BCMAS, CRQM has a diverse education history:

- Benedict C. attended the University of Utah, where they earned a Certificate in Business Management. The specific start and end years of this program are not provided.

- Following that, they pursued a Postdoc Scholar position at the University of Kentucky. Their field of study during this time included LTP (long-term potentiation), synaptic plasticity, brain injury, and cell/molecular biology. Again, the start and end years are not mentioned.

- Albensi then moved on to a Postdoc Fellow position at Georgetown University School of Medicine. Here, their research focused on MRI, brain injury, drugs, and plasticity. The timeframe for this position is not provided.

- Benedict C. later pursued a PhD at the University of Utah School of Medicine, specializing in neuroscience. Their research interests during this time included NMDA antagonists testing, brain hypoxia, and MRI. The start and end years of their PhD program are not mentioned.

- Albensi holds a Master's degree in Biology from Sonoma State University. No specific details are provided regarding the start and end years of this program.

- Benedict C. also obtained a Bachelor of Science (BS) degree in General Science from the University of Oregon. The specific timeframe for this undergraduate degree is not mentioned.

Additionally, Albensi has obtained several clinical research certifications and completed various training programs. Some of the certifications they hold include:

- CDR - Clinical Dementia Rating, obtained from Knight ADRC at Washington University in St. Louis, MO, in April 2019.

- MoCA - Montreal Cognitive Assessment, acquired in April 2019 from the official website of the test.

- Computer-Based Clinical Research Training from The National Institutes of Health, although the specific date of completion is not provided.

- Protecting Human Research Participants certification, completed through Protecting Human Research Participants (PHRP) Online Training, Inc., although the specific date of completion is not mentioned.

- Pharmacoeconomics certification from the Accreditation Council for Medical Affairs (ACMA) in April 2018.

- CRQM - Clinical Research Quality Manager from the Quality Management Institute (Florida), although the specific date of completion is not mentioned.

- Vaccine Trials: Methods and Best Practices certification acquired through Coursera in December 2012.

- NIH - Computer-based Clinical Research Training completed in May 2012, and NIH - Protecting Human Research Participants completed in April 2012, both through The National Institutes of Health.

- Tri-Council Policy Statement (TCPS) 2: Core - Ethical Conduct for Research Involving Humans Course from Health Canada | Santé Canada, completed in April 2012.

- BCMAS - Board Certification Medical Affairs Specialist from the Accreditation Council for Medical Affairs (ACMA) in December 2017.

Finally, Albensi has also participated in a course on Health Equity Research offered by The Johns Hopkins University and Coursera, although no specific details are provided regarding the completion date.